Real-time enrollment status for this astrocytoma, idh-mutant, grade 2 clinical trial
Current Status
Recruiting
Checked: July 13, 2026 at 6:44 AM UTC
| NCT Number | NCT06860594 |
| Recruiting Status | Recruiting |
| Condition | Astrocytoma, IDH-Mutant, Grade 2 |
| Phase | Clinical Trial |
| Target Enrollment | 30 participants |
| Active Locations | 43 sites in the US |
| Sponsor | National Cancer Institute (NCI) |
| Last Updated on CT.gov | June 30, 2026 (1 week ago) |
As of July 13, 2026: Clinical trial NCT06860594 is currently recruiting participants. This clinical trial study for astrocytoma, idh-mutant, grade 2 is actively seeking new participants at 43 locations across the United States. The study is sponsored by National Cancer Institute (NCI). This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06860594 is actively recruiting participants as of July 13, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 43 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06860594 was last updated 1 week ago (June 30, 2026). HelloStudys verifies this status automatically.